Supernus Pharmaceuticals (SUPN) Market Capitalization (2012 - 2026)
Supernus Pharmaceuticals (SUPN) reported Market Capitalization of $2.71 billion for Q2 2026, up 52.9% from $1.77 billion a year earlier but down 9.8% from the prior quarter.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Market Capitalization (2012 - 2026) Analysis & Trends
For FY2025, Supernus Pharmaceuticals posted Market Capitalization of $2.86 billion, up 41.7% from FY2024.
- Market Capitalization has a five-year compound annual growth rate of 16.5% (FY2020 to FY2025).
- By year, Market Capitalization came in at $2.02 billion in FY2024 (+27.3%), $1.58 billion in FY2023 (-18.2%), $1.94 billion in FY2022 (+24.6%) and $1.55 billion in FY2021 (+16.7%).
- Five-year quarterly Market Capitalization spans a low of $1.41 billion in Q3 2021 and a high of $3 billion in Q1 2026.
- Year over year, Market Capitalization has now increased in each of the last five quarters, with growth averaging 34.7% over the last eight quarters.
- The high point for year-over-year Market Capitalization in five years was Q1 2026 (growth of 63.6%); the low point was Q4 2023 (a decline of 18.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3 billion (Q1 2026), $2.86 billion (Q4 2025) and $2.73 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn |
| 10 | Supernus Pharmaceuticals | 2.40 Bn | 1.06 Bn | 185.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71 Bn |
| Mar 31, 2026 | 3.00 Bn |
| Dec 31, 2025 | 2.86 Bn |
| Sep 30, 2025 | 2.73 Bn |
| Jun 30, 2025 | 1.77 Bn |
| Mar 31, 2025 | 1.83 Bn |
| Dec 31, 2024 | 2.02 Bn |
| Sep 30, 2024 | 1.72 Bn |
| Jun 30, 2024 | 1.47 Bn |
| Mar 31, 2024 | 1.87 Bn |
| Dec 31, 2023 | 1.58 Bn |
| Sep 30, 2023 | 1.50 Bn |
| Jun 30, 2023 | 1.63 Bn |
| Mar 31, 2023 | 1.97 Bn |
| Dec 31, 2022 | 1.94 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 1.54 Bn |
| Mar 31, 2022 | 1.72 Bn |
| Dec 31, 2021 | 1.55 Bn |
| Sep 30, 2021 | 1.41 Bn |
API Access
Supernus Pharmaceuticals Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();